December 3 Product: Biocon Biologics Yesintek Indication: Crohns disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis The FDA on Monday signed off on Biocon Biologics Yesintek (ustekinumab-kfce), a biosimilar to Johnson & Johnsons blockbuster antibody Stelara
Freezing the reconstituted solution , crystallization damages the peptide
Semaglutide & Tirzepatide is a subcutaneous injection, meaning it is administered into the fatty tissue just beneath the skin
Sikiri et al., Bone, 1999, 24, 195202)
Before diving into the product reviews, let's talk about why GLP-1 medications trigger hair loss in the first place
Note that the arithmetic shown in the post is internally inconsistent, so its figures should not be relied on